As always, the 32nd Annual J.P. Morgan (JPM) Healthcare Conference offered an unparalleled partnering playground for pharmas and biotechs. Although the big players generated most of the headlines, hundreds of smaller companies looked to JPM as the setting where they might punch their ticket to success.